Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis-Reference-Cited by-同舟云学术

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis

Published:2015-08-26 Issue:2 Volume:18 Page:275-282
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Li Ka-Loh,Djoukhadar Ibrahim,Zhu Xiaoping,Zhao Sha,Lloyd Simon,McCabe Martin,McBain Catherine,Evans D. Gareth,Jackson Alan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/2/275/7640610/nov168.pdf

Reference21 articles.

1. Neurofibromatosis type 2 (NF2)

2. Multifocality in neurofibromatosis type 2;Evans;Neuro Oncol,2014

3. Immunohistochemical Demonstration of Vascular Endothelial Growth Factor in Vestibular Schwannomas Correlates to Tumor Growth Rate

4. VEGF and VEGF Receptor-1 Concentration in Vestibular Schwannoma Homogenates Correlates to Tumor Growth Rate

5. Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilateral vestibular schwannoma with a cooccurring meningioma in a child: a case report and review of literature;Annals of Medicine & Surgery;2024-05-22

2. Consensus guidelines for the management of vestibular schwannoma for low-and middle-income countries;J PAK MED ASSOC;2024

3. Low-dose GBCA administration for brain tumour dynamic contrast enhanced MRI: a feasibility study;Scientific Reports;2024-02-28

4. A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis;Pharmaceuticals;2023-09-11

5. Vestibular dysfunction in NF2–related schwannomatosis;Brain Communications;2023-03-02